Journal article
Triple inhaled therapy for asthma in Canada
Abstract
A significant number of patients with asthma have poor control on their current inhaled therapies, typically a combination of inhaled corticosteroids (ICS) and long-acting beta-2 adrenergic bronchodilators (LABA). Adding a long-acting antimuscarinic agent (LAMA) has been shown to improve asthma control and the availability of triple therapy formulations (ICS/LABA/LAMA) in a single inhaler device or single inhaler triple therapy (SITT) mitigates …
Authors
Chapman KR; Balter M; Bhinder S; Kaplan A; McIvor A; Papadopoulos P; Godbout K
Journal
Canadian Journal of Respiratory Critical Care and Sleep Medicine, Vol. 7, No. 5, pp. 250–257
Publisher
Taylor & Francis
Publication Date
September 3, 2023
DOI
10.1080/24745332.2023.2237972
ISSN
2474-5332